Our Head of Assay Feasibility, Dr John Tyson presented an e-poster at ECCVID last month – the ESCMID Conference on Coronavirus. The e-poster focuses on the independent, multi centre, clinical performance
QuantuMDx today announces a business update and the appointments of Jonathan O’Halloran as Chief Executive Officer and Neil Butler as Chairman of the Board, as the company begins its transition
To coincide with Cervical Cancer Prevention Week, QuantuMDx Group has announced the start of a field study with St George’s, University of London, to evaluate its human papilloma virus (HPV)
To mark the start of Cervical Cancer Prevention Week, we’ve devised an infographic to outline the burden of cervical cancer in low and middle income countries and highlight the need
Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend
QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the
